Corient Private Wealth
NUTX

Corient Private Wealth’s Nutex Health NUTX Stock Holding History

Corient Private Wealth’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
6,684
+325
+5% +$41.2K ﹤0.01% 1733
2026
Q1 		$604K Buy
+6,359
New +$780K ﹤0.01% 1931
2023
Q2 		– Sell
-175
Closed -$26.5K – 2131
2023
Q1 		$26.5K Sell
175
-9
-5% -$1.82K ﹤0.01% 1965
2022
Q4 		$52K Buy
+184
New +$35.3K ﹤0.01% 1623

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Corient Private Wealth's NUTX Position: Q2 2026 in Review

Corient Private Wealth increased its Nutex Health (NUTX) stake by 5.1% in Q2 2026, buying an estimated $41.2K and bringing the position to 6,684 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1733.

Corient Private Wealth first reported a position in NUTX in Q4 2022 and has held it in 4 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Corient Private Wealth held 6,684 shares of Nutex Health worth $1.14M as of Q2 2026.
  • Corient Private Wealth bought 325 Nutex Health shares in Q2 2026, an estimated $41.2K.
  • Nutex Health made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1733 holding.
  • Corient Private Wealth first reported a position in Nutex Health in Q4 2022 and has held it in 4 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.